The validity of the Distress Thermometer in female partners of men with prostate cancer.


Journal

European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 16 05 2017
revised: 04 04 2018
accepted: 22 08 2018
pubmed: 27 9 2018
medline: 15 5 2019
entrez: 26 9 2018
Statut: ppublish

Résumé

Female partners of prostate cancer (PCa) survivors experience heightened psychological distress that may be greater than that expressed by PCa patients. However, optimal approaches to detect distressed, or at risk of distress, partners are unclear. This study applied receiver operating characteristics analysis to evaluate diagnostic accuracy, sensitivity and specificity of the Distress Thermometer (DT) compared to widely used measures of general (Hospital Anxiety and Depression Scale) and cancer-specific (Impact of Events Scale-Revised) distress. Participants were partners of men with localised PCa (recruited around diagnosis) about to undergo or had received surgical treatment (N = 189), and partners of men diagnosed with PCa who were 2-4 years post-treatment (N = 460). In both studies, diagnostic utility of the DT overall was not optimal. Although area under the curve scores were acceptable (ranges: 0.71-0.92 and 0.83-0.94 for general and cancer-specific distress, respectively), sensitivity, specificity and optimal DT cut-offs for partner distress varied for general (range: ≥2 to ≥5) and cancer-specific (range: ≥3 to ≥5) distress both across time and between cohorts. Thus, it is difficult to draw firm conclusions about the diagnostic capabilities of the DT for partners or recommend its use in this population. More comprehensive screening measures may be needed to detect partners needing psychological intervention.

Identifiants

pubmed: 30252180
doi: 10.1111/ecc.12924
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Pagination

e12924

Subventions

Organisme : National Health and Medical Research Council
ID : ID496001
Organisme : Cancer Council Queensland

Informations de copyright

© 2018 John Wiley & Sons Ltd.

Auteurs

Melissa K Hyde (MK)

Cancer Council Queensland, Brisbane, Queensland, Australia.
Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.

Leah Zajdlewicz (L)

Cancer Council Queensland, Brisbane, Queensland, Australia.

Mark Lazenby (M)

School of Nursing, Yale University, New Haven, Connecticut.

Jeff Dunn (J)

Cancer Council Queensland, Brisbane, Queensland, Australia.
Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Institute for Resilient Regions, University of Southern Queensland, Toowoomba, Queensland, Australia.
School of Social Science, The University of Queensland, St Lucia, Queensland, Australia.

Kirstyn Laurie (K)

Cancer Council Queensland, Brisbane, Queensland, Australia.
Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.

Anthony Lowe (A)

Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.

Suzanne K Chambers (SK)

Cancer Council Queensland, Brisbane, Queensland, Australia.
Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Institute for Resilient Regions, University of Southern Queensland, Toowoomba, Queensland, Australia.
Faculty of Health, University of Technology Sydney, New South Wales, Australia.
Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH